Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 20
2014 38
2015 37
2016 42
2017 61
2018 66
2019 57
2020 71
2021 77
Text availability
Article attribute
Article type
Publication date

Search Results

441 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.
Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Bhardwaj R, et al. J Clin Transl Hepatol. 2018 Mar 28;6(1):105-113. doi: 10.14218/JCTH.2017.00035. Epub 2017 Dec 4. J Clin Transl Hepatol. 2018. PMID: 29577037 Free PMC article. Review.
Management of Hepatorenal Syndrome: A Review.
Tariq R, Singal AK. Tariq R, et al. J Clin Transl Hepatol. 2020 Jun 28;8(2):192-199. doi: 10.14218/JCTH.2020.00011. Epub 2020 Jun 1. J Clin Transl Hepatol. 2020. PMID: 32832400 Free PMC article. Review.
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.
Li J, Fan JG. Li J, et al. J Clin Transl Hepatol. 2020 Mar 28;8(1):13-17. doi: 10.14218/JCTH.2020.00019. Epub 2020 Mar 30. J Clin Transl Hepatol. 2020. PMID: 32274341 Free PMC article. Review.
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 2019, from Wuhan, China, has been posing a significant threat to global human health. The clinical features and outcomes of Chinese pat …
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 20 …
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review.
Tighe SP, Akhtar D, Iqbal U, Ahmed A. Tighe SP, et al. J Clin Transl Hepatol. 2020 Dec 28;8(4):454-458. doi: 10.14218/JCTH.2020.00012. Epub 2020 Oct 16. J Clin Transl Hepatol. 2020. PMID: 33447529 Free PMC article. Review.
Despite the use of silymarin being extensively studied in alcoholic liver disease, metabolic-associated fatty liver disease, viral hepatitis, and drug-induced liver injury, the overall efficacy of silymarin remains unclear and more research is warranted to better elucidate the ro …
Despite the use of silymarin being extensively studied in alcoholic liver disease, metabolic-associated fatty liver disease, viral hepatitis …
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.
Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH. Feng G, et al. J Clin Transl Hepatol. 2020 Mar 28;8(1):18-24. doi: 10.14218/JCTH.2020.00018. Epub 2020 Mar 30. J Clin Transl Hepatol. 2020. PMID: 32274342 Free PMC article. Review.
Based on the current evidence from case reports and case series, this review article focuses on the demographic and clinical characteristics, potential mechanisms, and treatment options for COVID-19-related liver dysfunction. ...
Based on the current evidence from case reports and case series, this review article focuses on the demographic and clinical characte …
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations.
Kumar R, Priyadarshi RN, Anand U. Kumar R, et al. J Clin Transl Hepatol. 2020 Mar 28;8(1):76-86. doi: 10.14218/JCTH.2019.00051. Epub 2019 Dec 28. J Clin Transl Hepatol. 2020. PMID: 32274348 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an innocuous condition, has now become the most common cause of chronic liver disease in many cou …
Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial pathogenesis and heterogenous clinical
Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update.
Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Yoon E, et al. J Clin Transl Hepatol. 2016 Jun 28;4(2):131-42. doi: 10.14218/JCTH.2015.00052. Epub 2016 Jun 15. J Clin Transl Hepatol. 2016. PMID: 27350943 Free PMC article. Review.
Although APAP hepatotoxicity follows a predictable timeline of hepatic failure, its clinical presentation might vary. N-acetylcysteine (NAC) therapy is considered as the mainstay therapy, but liver transplantation might represent a life-saving procedure for selected patien …
Although APAP hepatotoxicity follows a predictable timeline of hepatic failure, its clinical presentation might vary. N-acetylcystein …
441 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page